openPR Logo
Press release

United States Disposable Autoinjectors Market to hit US$ 3,073.24 Million by 2033 | Top Companies are Becton, Dickinson and Company, Ypsomed AG, Owen Mumford Inc, Dali Medical Devices

11-10-2025 11:05 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Disposable Autoinjectors Market

Disposable Autoinjectors Market

Disposable Autoinjectors Market Size reached US$ 712.30 Million in 2024 and is expected to reach US$ 3,073.24 Million by 2033, growing at a CAGR of 17.8% during the forecast period 2025-2033.

DataM Intelligence has released its latest report on the "Disposbale Autoinjectors Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

Nearly 50 drugs are formulated as combination products delivered via autoinjectors, with about 62% of these devices designed to be disposable.

According to IDF projections, 1 in 8 adults - around 853 million people - are expected to live with diabetes, marking a 46% increase.

Taisho Pharmaceutical launched Nanozora 30 mg, a TNFα inhibitor in a patient-friendly disposable autoinjector and syringe form, offering new treatment options for rheumatoid arthritis in 2024

Prefilled autoinjectors are projected to account for 61.55% of the disposable autoinjectors market share in 2024.

North America is projected to lead the global disposable autoinjectors market, holding a 43.17% share in 2024.

Asia-Pacific is the fastest-growing region in the disposable autoinjectors market, capturing 22.34% of the market share.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/disposable-autoinjectors-market?kb

United States: Recent Industry Developments
✅ October 2025: West Pharmaceutical Services launched a next-gen disposable autoinjector with improved ergonomics for self-administration.
✅ September 2025: Becton Dickinson expanded production capacity to meet rising demand for disposable autoinjectors in chronic disease management.
✅ August 2025: FDA approved new disposable autoinjector designs incorporating Bluetooth connectivity for dose tracking.

Japan: Recent Industry Developments
✅ October 2025: Terumo Corporation introduced eco-friendly disposable autoinjectors with biodegradable components.
✅ September 2025: Japanese pharma companies adopted disposable autoinjectors for biologics targeting autoimmune diseases.
✅ August 2025: Collaborative research advanced needle-free disposable injection technologies to enhance patient compliance.

Key Player:

Becton, Dickinson, and Company, Ypsomed AG, Owen Mumford Inc., Phillips Medisize, SHL Medical, Stevanato Group, Faxne, and Dali Medical Devices, among others.

Key Industry Developments:

In April 2025, argenx SE announced that the FDA approved a new self-injection option for VYVGART Hytrulo, a prefilled syringe (efgartigimod alfa and hyaluronidase-qvfc) to treat adults with generalized myasthenia gravis (gMG) who are anti-AChR antibody positive, as well as chronic inflammatory demyelinating polyneuropathy (CIDP) patients.

In January 2025, UCB introduced a 2 mL single-injection prefilled syringe and autoinjector, each containing 320 mg of BIMZELX (bimekizumab-bkzx), complementing the existing 1 mL, 160 mg options.

In November 2024, Amneal Pharmaceuticals resubmitted its NDA to the FDA for a dihydroergotamine (DHE) prefilled syringe autoinjector aimed at acute treatment of migraines (with or without aura) and cluster headaches in adults.

Forecast Projection:

The global Disposbale Autoinjectors market is set to witness strong growth from 2025 to 2032. After maintaining steady momentum in 2024, the market is expected to accelerate as key industry players implement strategic initiatives to boost adoption. Companies that adapt to these emerging trends will be well-positioned to capture new opportunities and enhance their revenue potential throughout the forecast period.

Market Intelligence Research Process:

The Disposbale Autoinjectors Market Report by DataM Intelligence offers a comprehensive analysis built on a mix of primary and secondary research. It explores key factors driving the industry, including government policies, market trends, competitive landscape, technological advancements, and upcoming innovations. This in-depth study uncovers both growth opportunities and potential challenges, helping businesses navigate market fluctuations and make data-driven decisions for sustainable success.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=disposable-autoinjectors-market?kb

Key Segmentations:

By Type: (Prefilled Autoinjectors, Fillable Autoinjectors)

By Application: (Diabetes, Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Others)

By End-User: (Hospitals, Specialty Clinics, Homecare Settings, Others)

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/disposable-autoinjectors-market?kb

FAQ's

Q1: How large is the Disposbale Autoinjectors Market?

Ans: The Disposbale Autoinjectors Market size was valued at US$ 712.30 Million in 2024 and is projected to grow to US$ 3,073.24 Million by 2033.

Q2: How quickly is the Disposbale Autoinjectors Market expanding?

Ans: The Disposbale Autoinjectors Market is forecasted to grow at a CAGR of 17.8% between 2025 and 2032, showing Annual growth momentum

Q3: Which regions are dominating the Disposbale Autoinjectors Market and which are fastest-growing?

Ans: North America dominating the Disposbale Autoinjectors market.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/disposable-autoinjectors-market?kb

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Linkedin: https://www.linkedin.com/company/datam-intelligence/
Twitter: https://x.com/DataM_Research

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Disposable Autoinjectors Market to hit US$ 3,073.24 Million by 2033 | Top Companies are Becton, Dickinson and Company, Ypsomed AG, Owen Mumford Inc, Dali Medical Devices here

News-ID: 4261465 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031, Driven by Supplements and Functional Foods Demand | DataM Intelligence
Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031 …
The Global Nutritional Ingredients Market was valued at USD 182.5 billion in 2022 and is projected to reach USD 325.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. This robust growth is driven by a profound and global consumer shift towards health and wellness, the accelerating adoption of vegan and plant-based lifestyles, an aging global population seeking preventative nutrition, and the rapid expansion of
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading companies - Toyal America Inc, Hunan Ningxiang Jiweixin Metal Powder Co., Ltd., ECKA Granules
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" Global Aluminum Powder Market Size reached US$ 7.32 billion in 2024 and is expected to reach US$ 12.39 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2025-2032." Lightweight materials demand and additive manufacturing growth are boosting aluminum powder usage. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/aluminum-powder-market?Prasad United States: Recent Industry
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billion by 2033 | Leading companies - Bayer AG, Haleon group of companies, Kenvue, Teva Pharmaceutical Industries Ltd
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billi …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The North America non-steroidal anti-inflammatory drugs market size reached US$ 8.34 billion in 2024 and is expected to reach US$ 17.27 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033." Chronic pain prevalence and OTC self-care trends continue to strengthen the NSAIDs market. Download your exclusive sample report today: (corporate email gets priority access):
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading companies - Alnylam Pharmaceuticals, Inc., NOVARTIS AG, Sarepta Therapeutics, Inc.
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The US Gene Therapy Market Size reached US$ 2,812.92 million in 2024 and is expected to reach US$ 21,701.51 million by 2033, growing at a CAGR of 23.5 % during the forecast period 2025-2033." Advances in viral vectors and precision medicine are driving rapid progress in the US gene therapy market. Download your exclusive sample report today: (corporate

All 5 Releases


More Releases for Autoinjectors

Elevated Prevalence Of Chronic Diseases Sparks Growth In The Autoinjectors Marke …
The Autoinjectors Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Autoinjectors Market? In recent times, the autoinjectors market has experienced substantial growth. Projections indicate that it will expand from a valuation of $3.7 billion in 2024 to $4.55 billion
Automated Autoinjectors Market
The "Automated Autoinjectors Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Automated Autoinjectors Market, 2024-2031 Verified Market Research's most recent report, "Automated Autoinjectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination
Autoinjectors Market worth $ 226.37 Million by 2030
Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Autoinjectors Market- by Type (Disposable Autoinjectors and Reusable Autoinjectors) Applications (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis and Others), End-User (Home care settings and Hospitals & Clinics), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1234 According to the latest research by Insightace Analytics, the global autoinjectors market was valued at US$ 47.13 Million
Reusable Autoinjectors Market Size - Forecast to 2026
As per the research conducted by GME, the Global Reusable Autoinjectors Market is projected to grow at a CAGR value of 11.7% during the forecast period [2021 to 2026]. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Reusable Autoinjectors Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/reusable-autoinjectors-market-3325 By Dose (Fixed and Variable), By Technology (Smart Autoinjectors, Conventional Autoinjectors) By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple
Autoinjectors Market 2022 Trends and Review
ReportsWeb.com has announced the addition of the “Global Autoinjectors Market Research Report 2017” The report focuses on global major leading players with information such as company profiles, product picture and specification. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Autoinjectors in these regions, from 2012 to 2022 (forecast) , covering North America, Europe, China, Japan, Southeast Asia
Autoinjectors Market 2016: Disposable Autoinjectors, Reusable Autoinjectors
Autoinjector is a medical device used to dispense a single dose of a drug, particularly, life-saving drugs. These Autoinjectors are usually spring-loaded syringes that are particularly designed for easy and safe administration of the drugs. The injectable drug delivery method is a technology driven market and has experienced a paradigm shift. The traditionally used self-injection devices, which were merely used for delivering human growth hormones and insulin are currently replaced